Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Immunovant, Inc. | Director | Common Stock | 125K | $4.52M | $36.15 | Apr 2, 2024 | Direct |
Eargo, Inc. | Director | Common Stock | 107K | $277K | $2.59 | Nov 22, 2022 | Direct |
Immunovant, Inc. | Director | Stock Option (right to buy) | 4.69K | Apr 2, 2024 | Direct | ||
Eargo, Inc. | Director | Subscription Rights (right to buy) | 0 | Nov 23, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMVT | Immunovant, Inc. | Apr 2, 2024 | 2 | $0 | 4 | Apr 4, 2024 | Director |
IMVT | Immunovant, Inc. | Apr 12, 2023 | 2 | $0 | 4 | Apr 14, 2023 | Director |
EAR | Eargo, Inc. | Nov 22, 2022 | 2 | $35.7K | 4 | Nov 25, 2022 | Director |
EAR | Eargo, Inc. | Oct 12, 2022 | 1 | $0 | 4 | Oct 14, 2022 | Director |
EAR | Eargo, Inc. | Aug 23, 2022 | 1 | $0 | 4 | Aug 25, 2022 | Director |
IMVT | Immunovant, Inc. | Aug 17, 2022 | 2 | $0 | 4 | Aug 19, 2022 | Director |
IMVT | Immunovant, Inc. | Jan 10, 2022 | 2 | $0 | 4 | Jan 12, 2022 | Director |
IMVT | Immunovant, Inc. | Aug 27, 2021 | 1 | $150K | 4 | Aug 30, 2021 | Director |